Sofinnova Partners
56 portfolio companies · 8 on the map · $480.9M raised · 6 cities
Portfolio map
8 Sofinnova Partners portfolio companies on the map.
Portfolio companies

Tissium
Paris
TISSIUM develops biodegradable sealants and adhesives for wound closure in the field of minimally-invasive surgery.
Medical Equipment Manufacturing$210MEst. 2013
Bioptimus
Paris
We build foundation models that will transform biology.
Biotech$76MEst. 2024
myTomorrows
Amsterdam
myTomorrows is a global platform that connects patients with unmet medical needs to treatments in development around the world.
Hospitals and Health Care$51.1MEst. 2012
Berry Street
New York
Berry Street is a platform enabling Registered Dietitians to launch and grow private practices. Since its January 2023 launch, it has raised funding from Village Global and angel founders of Elemy and Grow Therapy.
SaaS$50MEst. 2023Hiring fast- NT
Nitrase Therapeutics
Brisbane
Nitrase Therapeutics is developing drugs against newly discovered nitration enzyme(s).
Biotechnology Research$45MEst. 2018 
EnginZyme
Solna
EnginZyme is a biotechnology company that creates biomanufacturing techniques for the sustainable production of common goods.
Biotech$20.2MEst. 2014
Kiro
Paris
Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.
AI & machine learning$16.2MEst. 2019
GlycoEra
Zurich
Advancing Glycan Mediated Therapy
Biotech$12.4MEst. 2020
More portfolio companies
48 more Sofinnova Partners investments we track beyond the map.
AbivaxParis · Post-IPO Equity
Latent LabsLondon · Series A
AAVantgarde BioMilano · Series B
Galvanize TherapeuticsRedwood City · Series C
nChroma BioBoston · Venture
BrightHeartParis · Series A
BetteromicsRedwood City · Series A
CinCor PharmaCincinnati · Series B
SynthaceLondon · Series C
Moon SurgicalParis · Series B
Amolyt PharmaÉcully · Series C
Noema PharmaBasel · Series B
NanoPhoriaMilan · Series A
deepcMunich · Series A
Myricx BioLondon · Series A
May HealthParis · Venture
DMC BiotechnologiesBoulder · Series B
F2GManchester · Private Equity
Mnemo TherapeuticsParis · Series A
InCarda TherapeuticsNewark · Series B
HighLifeParis · Series B
Inventiva PharmaDaix · Post-IPO Equity
Catamaran BioBoston · Series A
CorVent MedicalFargo · Seed
Sphere BioCambridge · Venture
BioCorteXLondon · Seed
Crescendo BiologicsCambridge · Venture
Shockwave MedicalFremont · Series D
Altamira TherapeuticsBasel · Series C
Hookipa PharmaNew York · Series C
ZylSaint-maur-des-fossés · Venture
QosmosParis · Series C
AccentItá · Venture
TwengaParis · Series A
WyplayAllauch · Series A
- AAvakiBurlington · Series A
blueKiwi softwareParis · Series B
BoostWorksSan Francisco · Series B
GlycoVaxynSchlieren · Series B
Sensitive ObjectBoulogne-billancourt · Series B
MXP4Paris · Series B
QuesComValbonne · Venture
Tak ImagingSan Mateo · Series C
EOS (Ethical Oncology Science)Milan · Series A
Ingenium PharmaceuticalsPlanegg · Series B
Revolt TechnologyPortland · Series B
CotherixSan Francisco · Series C
MD StartParis · Venture
Portfolio map
8 Sofinnova Partners portfolio companies on the map.